Recombinant Human Carbonic Anhydrase 9 / CA9 Protein (Active)
- Premium Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human Carbonic Anhydrase 9 / CA9 Protein (Active) is a Human Fragment protein, in the 59 to 414 aa range, expressed in HEK 293 cells, with >95%, <0.005 EU/µg endotoxin level, suitable for HPLC, Mass Spec, SDS-PAGE, FuncS.
View Alternative Names
G250, MN, CA9, Carbonic anhydrase 9, Carbonate dehydratase IX, Carbonic anhydrase IX, Membrane antigen MN, P54/58N, Renal cell carcinoma-associated antigen G250, pMW1, CA-IX, CAIX, RCC-associated antigen G250
- Biological Activity
Supplier Data
Biological Activity - Recombinant Human Carbonic Anhydrase 9 / CA9 Protein (Active) (AB290062)
Fully active measured by its esterase activity. The specific activity is ≥ 200 pmol/min/ug.
- Mass Spec
Supplier Data
Mass Spectrometry - Recombinant Human Carbonic Anhydrase 9 / CA9 Protein (Active) (AB290062)
Mass determination by ESI-TOF. Predicted MW is 38810.99 Da (+/-10 Da by ESI-TOF). Observed MW is 38812.95 Da.
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human Carbonic Anhydrase 9 / CA9 Protein (Active) (AB290062)
SDS-PAGE analysis of ab290062
- HPLC
Supplier Data
HPLC - Recombinant Human Carbonic Anhydrase 9 / CA9 Protein (Active) (AB290062)
HPLC analysis of ab290062
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Specifications
Form
Liquid
Additional notes
SDS-PAGE >= 95%
General info
Function
Catalyzes the interconversion between carbon dioxide and water and the dissociated ions of carbonic acid (i.e. bicarbonate and hydrogen ions).
Sequence similarities
Belongs to the alpha-carbonic anhydrase family.
Post-translational modifications
Asn-346 bears high-mannose type glycan structures.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com